Diabetes mellitus impairs myocardial oxygen metabolism even in non-infarct-related areas in patients with acute myocardial infarction

International Journal of Cardiology

Volumn 115, Issue 3, 2007, Pages 297-304

  Toyoda, Kiyohiro ^a   Nakano, Akira ^a   Fujibayashi, Yasuhisa ^a   Yonekura, Yoshiharu ^a   Ueda, Takanori ^a   Lee, Jong Dae ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Diabetes mellitus; Myocardial oxygen metabolism; Non infarct related area; Positron emission tomography

Indexed keywords

ACETIC ACID C 11;

ACUTE HEART INFARCTION; AGED; ARTICLE; CLEARANCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE PERFUSION; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SEX DIFFERENCE;

ADULT; AGE DISTRIBUTION; AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; OXYGEN CONSUMPTION; POSITRON-EMISSION TOMOGRAPHY; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33846580990     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.03.012     Document Type: Article

References (28)

1. Jaffe A.S., Spadaro J.J., Schechtman K., Roberts R., Geltman E.M., and Sobel B.E. Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus. Am Heart J 108 (1984) 31-37
2. Malmberg K., Norhammar A., Wedel H., and Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 99 (1999) 2626-2632
3. Takahashi N., Iwasaka T., Sugiura T., et al. Left ventricular regional function after acute anterior myocardial infarction in diabetic patients. Diabetes Care 12 (1989) 630-635
4. Iwasaka T., Takahashi N., Nakamura S., et al. Residual left ventricular pump function after acute myocardial infarction in NIDDM patients. Diabetes Care 15 (1992) 1522-1526
5. Hattori N., Tamaki N., Kudoh T., et al. Abnormality of myocardial oxidative metabolism in noninsulin-dependent diabetes mellitus. J Nucl Med 39 (1998) 1835-1840
6. Di Carli M.F., Janisse J., Grunberger G., and Ager J. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 41 (2003) 1387-1393
7. Sugiyama T., Kurata C., Tawarahara K., and Nakano T. Is abnormal iodine-123-MIBG kinetics associated with left ventricular dysfunction in patients with diabetes mellitus?. J Nucl Cardiol 7 (2000) 562-568
8. Kramer C.M., Nicol P.D., Rogers W.J., et al. Reduced sympathetic innervation underlies adjacent noninfarcted region dysfunction during left ventricular remodeling. J Am Coll Cardiol (1997) 1079-1085
9. Nakano A., Lee J.D., Shimizu H., Yonekura Y., and Ueda T. Clinical significance of augmented fluorine-18 deoxyglucose uptake in remote normoperfused myocardium in patients with acute coronary syndrome under fasting conditions. J Nucl Cardiol 7 (2000) 454-460
10. Brown M.A., Myears D.W., and Bergmann S.R. Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization. J Nucl Med 30 (1989) 187-193
11. 11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. Circulation 81 (1990) 1594-1605
12. Austen W.G., Edwards J.E., Frye R.L., et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 51 (1975) 5-40
13. Nakano A., Lee J.D., Shimizu H., et al. Clinical significance of reverse redistribution on resting thallium-201 imaging in patients with vasospastic angina. Ann Nucl Med 15 (2001) 65-68
14. Brown M., Marshall D.R., Sobel B.E., and Bergmann S.R. Delineation of myocardial oxygen utilization with carbon-11-labeled acetate. Circulation 76 (1987) 687-696
15. Kawai Y., Tsukamoto E., Nozaki Y., Morita K., Sakurai M., and Tamaki N. Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain. J Am Coll Cardiol 38 (2001) 1888-1894
16. Glantz S.A. It is all in the numbers. J Am Coll Cardiol 21 (1993) 835-837
17. Shug A.L., Shrago E., Bittar N., Folts J.D., and Koke J.R. Acyl-CoA inhibition of adenine nucleotide translocation in ischemic myocardium. Am J Physiol 228 (1975) 689-692
18. Scheuermann-Freestone M., Madsen P.L., Manners D., et al. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation 107 (2003) 3040-3046
19. Walsh M.N., Geltman E.M., Brown M.A., et al. Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography with carbon-11 acetate in patients with myocardial infarction. J Nucl Med 30 (1989) 1798-1808
20. Maes A.F., Van de Werf F., Mesotten L.V., et al. Early assessment of regional myocardial blood flow and metabolism in thrombolysis in myocardial infarction flow grade 3 reperfused myocardial infarction using carbon-11-acetate. J Am Coll Cardiol 37 (2001) 30-36
21. Kalff V., Hicks R.J., Hutchins G., Topol E., and Schwaiger M. Use of carbon-11 acetate and dynamic positron emission tomography to assess regional myocardial oxygen consumption in patients with acute myocardial infarction receiving thrombolysis or coronary angioplasty. Am J Cardiol 71 (1993) 529-535
22. Ohte N., Kurokawa K., Iida A., et al. Myocardial oxidative metabolism in remote normal regions in the left ventricles with remodeling after myocardial infarction: effect of beta-adrenoceptor blockers. J Nucl Med 43 (2002) 780-785
23. Henes C.G., Bergmann S.R., Walsh M.N., Sobel B.E., and Geltman E.M. Assessment of myocardial oxidative metabolic reserve with positron emission tomography and carbon-11 acetate. J Nucl Med (1989) 1489-1499
24. Prigent F., Maddahi J., Garcia E.V., Satoh Y., Van Train K., and Berman D.S. Quantification of myocardial infarct size by thallium-201 single-photon emission computed tomography: experimental validation in the dog. Circulation 74 (1986) 852-861
25. Uren N.G., Marraccini P., Gistri R., de Silva R., and Camici P.G. Altered coronary vasodilator reserve and metabolism in myocardium subtended by normal arteries in patients with coronary artery disease. J Am Coll Cardiol (1993) 650-658
26. Brosius III F.C., Liu Y., Nguyen N., Sun D., Bartlett J., and Schwaiger M. Persistent myocardial ischemia increases GLUT1 glucose transporter expression in both ischemic and non-ischemic heart regions. J Mol Cell Cardiol 29 (1997) 1675-1685
27. Sherman A.J., Klocke F.J., Decker R.S., et al. Myofibrillar disruption in hypocontractile myocardium showing perfusion-contraction matches and mismatches. Am J Physiol Heart Circ Physiol 278 (2000) H1320-H1334
28. Norhammar A., Tenerz A., Nilsson G., et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359 (2002) 2140-2144